Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
Jan 07, 08:05 PM
Share
Subscribe
In today’s Pharmaceutical Executive Daily, Amgen announces an $840 million acquisition of Dark Blue Therapeutics, GSK enters a multi-year precision medicine collaboration with Helix, and industry leaders examine how workable operating models are reshaping cell and gene therapy commercialization.